Analysis of the interaction between HSD17B10 and the tumor immune microenvironment demonstrated that its expression positively correlated with ESTIMATE scores in GBM-LGG, LGG, and UVM, suggesting a potential role in promoting tumor progression through enhanced stromal and immune cell infiltration [28]. The gene discussed is HSD17B10; the disease is neoplasm.